<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000674702"><TermName>Aurora B/C kinase inhibitor GSK1070916A</TermName><TermPronunciation>(uh-ROR-uh … KY-nays in-HIH-bih-ter …)</TermPronunciation><TermDefinition><DefinitionText>A substance
          being studied in the treatment of some types of cancer. It
          blocks certain enzymes (Aurora kinases) involved in cell
          division and may kill cancer cells. It is a type of
          serine/threonine protein kinase inhibitor. Also called GSK1070916A.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000727634" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Aurora B/C kinase inhibitor GSK1070916A&quot;" language="en" id="_3"/><MediaLink ref="CDR0000727633" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de la cinasa de la aurora B y C GSK1070916A&quot;" language="es" id="_4"/><SpanishTermName>inhibidor de la cinasa de la aurora B y C GSK1070916A</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de ciertos tipos de cáncer. Impide el funcionamiento de ciertas enzimas (Cinasas de la aurora ) que participan en la multiplicación celular y podría eliminar las células cancerosas. Es un tipo de inhibidor de la proteína cinasa serina/treonina. También se llama GSK1070916A.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-10-11</DateFirstPublished></GlossaryTerm>
